Clinical experience with bromperidol on chronic psychoses
Bromperidol therapeutic efficacy, and tolerance was studied by means of a 3-month open trial on 25 chronic psychotic female inpatients from a room at San Juan ward for medium to extensive length of stay, The Braulio A. Moyano National Psychiatric Hospital, Buenos Aires. This drug was administered or...
| Publicado: |
1988
|
|---|---|
| Materias: | |
| Acceso en línea: | https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00016896_v34_n3_p230_Bellomo http://hdl.handle.net/20.500.12110/paper_00016896_v34_n3_p230_Bellomo |
| Aporte de: |
| id |
paper:paper_00016896_v34_n3_p230_Bellomo |
|---|---|
| record_format |
dspace |
| spelling |
paper:paper_00016896_v34_n3_p230_Bellomo2023-06-08T14:21:04Z Clinical experience with bromperidol on chronic psychoses bromperidol haloperidol bromperidol drug derivative haloperidol adult catatonia clinical article delusion drug efficacy drug tolerance female human oral drug administration psychological aspect psychosis schizophrenia adolescent aged article chronic disease clinical trial paranoid psychosis patient psychosis schizophrenia Adolescent Adult Aged Chronic Disease Clinical Trials English Abstract Female Haloperidol Human Inpatients Middle Age Paranoid Disorders Psychotic Disorders Schizophrenia Bromperidol therapeutic efficacy, and tolerance was studied by means of a 3-month open trial on 25 chronic psychotic female inpatients from a room at San Juan ward for medium to extensive length of stay, The Braulio A. Moyano National Psychiatric Hospital, Buenos Aires. This drug was administered orally on a single 10 to 35 mg night dose. No effect whatsoever was observed on periodic catatonia. However, its being well-tolerated and effective on chronic psychotic patients, coupled to the 'bonus' of a single daily dose, turns BP into a suitable alternative drug for Haloperidol when dealing with schizophrenia, and delusions with no deficitary evolution. 1988 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00016896_v34_n3_p230_Bellomo http://hdl.handle.net/20.500.12110/paper_00016896_v34_n3_p230_Bellomo |
| institution |
Universidad de Buenos Aires |
| institution_str |
I-28 |
| repository_str |
R-134 |
| collection |
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) |
| topic |
bromperidol haloperidol bromperidol drug derivative haloperidol adult catatonia clinical article delusion drug efficacy drug tolerance female human oral drug administration psychological aspect psychosis schizophrenia adolescent aged article chronic disease clinical trial paranoid psychosis patient psychosis schizophrenia Adolescent Adult Aged Chronic Disease Clinical Trials English Abstract Female Haloperidol Human Inpatients Middle Age Paranoid Disorders Psychotic Disorders Schizophrenia |
| spellingShingle |
bromperidol haloperidol bromperidol drug derivative haloperidol adult catatonia clinical article delusion drug efficacy drug tolerance female human oral drug administration psychological aspect psychosis schizophrenia adolescent aged article chronic disease clinical trial paranoid psychosis patient psychosis schizophrenia Adolescent Adult Aged Chronic Disease Clinical Trials English Abstract Female Haloperidol Human Inpatients Middle Age Paranoid Disorders Psychotic Disorders Schizophrenia Clinical experience with bromperidol on chronic psychoses |
| topic_facet |
bromperidol haloperidol bromperidol drug derivative haloperidol adult catatonia clinical article delusion drug efficacy drug tolerance female human oral drug administration psychological aspect psychosis schizophrenia adolescent aged article chronic disease clinical trial paranoid psychosis patient psychosis schizophrenia Adolescent Adult Aged Chronic Disease Clinical Trials English Abstract Female Haloperidol Human Inpatients Middle Age Paranoid Disorders Psychotic Disorders Schizophrenia |
| description |
Bromperidol therapeutic efficacy, and tolerance was studied by means of a 3-month open trial on 25 chronic psychotic female inpatients from a room at San Juan ward for medium to extensive length of stay, The Braulio A. Moyano National Psychiatric Hospital, Buenos Aires. This drug was administered orally on a single 10 to 35 mg night dose. No effect whatsoever was observed on periodic catatonia. However, its being well-tolerated and effective on chronic psychotic patients, coupled to the 'bonus' of a single daily dose, turns BP into a suitable alternative drug for Haloperidol when dealing with schizophrenia, and delusions with no deficitary evolution. |
| title |
Clinical experience with bromperidol on chronic psychoses |
| title_short |
Clinical experience with bromperidol on chronic psychoses |
| title_full |
Clinical experience with bromperidol on chronic psychoses |
| title_fullStr |
Clinical experience with bromperidol on chronic psychoses |
| title_full_unstemmed |
Clinical experience with bromperidol on chronic psychoses |
| title_sort |
clinical experience with bromperidol on chronic psychoses |
| publishDate |
1988 |
| url |
https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00016896_v34_n3_p230_Bellomo http://hdl.handle.net/20.500.12110/paper_00016896_v34_n3_p230_Bellomo |
| _version_ |
1768541964314083328 |